AKT1 and gastric cancer: Up to now, the mechanisms observed widely for PI3K/AKT activation in gastric cancer include somatic activating mutations and amplifications in p110α (6–8), loss of the PTEN tumor suppressor (8), and genetic amplifications of AKT1 (9).